HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

47.140

-1.300-2.68%

Volume:4.75M

Turnover:226.87M

Market Cap:312.87B

PE:34.09

High:49.100

Open:48.980

Low:46.480

Close:48.440

52wk High:90.435

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:2.75

T/O Rate:1.84%

Dividend:0.23

Dividend Rate:0.50%

EPS(LYR):1.383

ROE:12.46%

ROA:7.02%

PB:4.14

PE(LYR):34.09

PS:8.52

Loading ...

Overview Company News Filings

Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic

HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 6.91%

Hengrui Pharma's NewCo Partner Debuts on Nasdaq Following Kailera

AH Share Premium Ranking Summary for August 10

Hengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets

MT Newswires Live

Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals

Hengrui Pharma Prioritizes Stable Business Performance to Sustain Long-Term Value and Reward Shareholders

HENGRUI PHARMA Continues to Reward Shareholders Through Dividends and Other Methods

Jiangsu Hengrui Pharmaceuticals Focuses on Core Business Growth

Citigroup's Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 1.39% on Aug 3 from 2.36% - HKEX

THOMSON REUTERS

August 7th A-H Share Premium Data Summary

HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval

Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications

Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China

MT Newswires Live

Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan

Bulletin Express

Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)

THOMSON REUTERS

Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China

THOMSON REUTERS

JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis

Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection

Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/01276/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":47.14,"timestamp":1791518396531,"preClose":48.44,"halted":0,"volume":4747800,"delay":0,"changeRate":-0.026837324525185738,"floatShares":258000000,"shares":6637000000,"eps":1.3825870701426706,"marketStatus":"Noon Closed","change":-1.3,"latestTime":"10-09 11:59:56","open":48.98,"high":49.1,"low":46.48,"amount":226867558,"amplitude":0.054088,"askPrice":47.24,"askSize":5000,"bidPrice":47.14,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":1.3634769047918003,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791522000000},"marketStatusCode":3,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.44,"dividendRate":0.004962,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":2.749573,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.63,"timestamp":1791516599000,"preClose":47.01,"halted":0,"volume":38879200,"delay":0,"premium":"-13.72"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.382652,"volumeRatio":2.749573,"shares":6637000000,"dividePrice":0.234348,"high":49.1,"amplitude":0.054088,"preClose":48.44,"low":46.48,"week52Low":43.02,"pbRate":"4.14","psRate":"8.52","week52High":90.435,"institutionHeld":0,"latestPrice":47.14,"committee":-0.666667,"eps":1.3826518920785393,"divideRate":0.004971,"volume":4747800,"delay":0,"ttmEps":1.363540830756674,"open":48.98,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":49.66,"twentyDayClose":43.96,"sixtyDayClose":57.95,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-08","current":34.571755,"percent":0.120235,"low":36.382401,"twenty":42.928092,"median":51.24762,"eighty":56.79448,"high":65.582363,"avg":50.547368,"sd":7.720082,"marketCap":362492038311.23},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-08","current":40.08793,"twenty":42.928092,"median":51.24762,"eighty":56.79448,"marketCap":362492038311.23}],"updateTime":1791518501240},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1180135180","title":"Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic","url":"https://stock-news.laohu8.com/highlight/detail?id=1180135180","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180135180?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:51","pubTimestamp":1786499503,"startTime":"0","endTime":"0","summary":"Abstract HENGRUI PHARMA will report results on August 19, 2026, post-Market; this preview compiles the latest quarter’s performance and consensus expectations, focusing on revenue, margins, EPS...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: HENGRUI PHARMA Q2 revenue is expected to increase, and institutional views are cautiously optimistic","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132656558","title":"HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132656558","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132656558?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:15","pubTimestamp":1786439716,"startTime":"0","endTime":"0","summary":"Wellington Management Group LLP sold 508,285 shares of HENGRUI PHARMA stock at an average of HKD 58.3601 per share on August 10, 2026, involving about HKD 29.66 million.Prior to the disposal,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137013945","title":"Hengrui Pharma's NewCo Partner Debuts on Nasdaq Following Kailera","url":"https://stock-news.laohu8.com/highlight/detail?id=1137013945","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137013945?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:12","pubTimestamp":1786363960,"startTime":"0","endTime":"0","summary":"Hengrui Pharma announced on August 9 that its partner, Braveheart Bio, successfully listed on the Nasdaq on August 6 local time. The IPO raised approximately $439.9 million, including the full...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","BK0028","LU1655091616.SGD","NDAQ","LU1997245094.SGD","01276","LU2097828714.EUR","LU2580892789.USD","LU1064130708.USD","BK0188","IE00BKPKM429.USD","LU1255011170.USD","BK0183","LU2097828805.USD","LU1146622755.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4588","IE00BN0W2W23.USD","600276","SG9999014005.SGD","IE00BN0W2V16.EUR","LU2097828557.USD","LU2328871848.SGD","BK0196","LU0405327494.USD","LU1328615791.USD","LU2289578879.USD","BK0060","LU1997244956.HKD","LU2148510915.USD","BK4112","LU1969619763.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","LU1580142542.USD","BK0012","LU2097828631.EUR","LU1064131003.USD","LU2580892862.HKD","BK0239","LU1820825898.SGD","LU2097828474.EUR","LU2095319765.USD","LU0314104364.USD","LU1781817850.SGD","LU1997245177.USD","LU2210150020.SGD","LU2495084118.USD","SG9999014021.USD","LU0405327148.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169979764","title":"AH Share Premium Ranking Summary for August 10","url":"https://stock-news.laohu8.com/highlight/detail?id=1169979764","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169979764?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:25","pubTimestamp":1786350306,"startTime":"0","endTime":"0","summary":"As of the close on August 10, the top three positions in the AH premium ranking were held by NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premium rates of 1011.11%,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06613","LU0359201885.HKD","03750","IE00B031HY20.USD","LU0828237510.HKD","06745","LU0865486749.SGD","LU0441854154.USD","LU0054450605.USD","LU0651946864.USD","LU0417516902.SGD","BK1551","BK1506","01108","LU1807302812.USD","PAImain","HK0000151867.HKD","LU0196878994.USD","LU2543165471.USD","IE00BGHQDM52.EUR","LU1244550577.SGD","LU2125910500.SGD","BK1502","BK1513","399300","LU0823426308.USD","LU0072462343.USD","00991","LU1282649141.HKD","LU1808992512.USD","LU0630378692.HKD","LU0878004406.USD","03308","LU0702159343.USD","LU1880383366.USD","LU1235295612.USD","BK1554","LU0235996351.USD","LU0456846285.SGD","LU0791590937.USD","LU0449509016.USD","LU1675838814.USD","BK1163","LU0052750758.USD","LU0821914370.USD","LU0862451837.USD","LU1023057109.AUD","LU0348814723.USD","LU1146622755.USD","LU0831093199.SGD","IE00BF5LJ272.USD","IE00B0169L03.USD","IE00B031J352.USD","BK1170","LU0588545490.SGD","LU0762542818.HKD","LU1224444064.USD","LU0320764599.SGD","IE00BVYPNQ40.USD","LU0314109678.HKD","LU0106959298.USD","LU1366334651.USD","LU1051769294.HKD","LU0588545904.SGD","LU0327786744.USD","LU0348784397.USD","LU1820825898.SGD","BK1550","00553","LU0675040207.SGD","LU2399975544.HKD","LU0791591158.USD","01349","BK1558","LU0072913022.USD","LU0049112450.USD","SG9999000459.SGD","SG9999002562.SGD","02865","LU2294711473.HKD","LU0348783233.USD","LU0043850808.USD","LU0348767384.USD","BK1144","BK1505","LU1282651048.USD","LU0315178854.USD","BK1240","LU0762540952.USD","BK1151","LU0106252389.USD","LU0164865239.USD","BK1147","HK0000306701.USD","SG9999011746.SGD","LU0228367735.SGD","HPAD.SI","LU0605514214.HKD","LU1188198961.HKD","LU0320764755.SGD","LU0488056044.USD","02475","LU0165289439.USD","SG9999002828.SGD","IE0031814852.USD","LU1961090484.USD","LU0348825331.USD","LU0348788117.USD","LU0634319403.HKD","LU0650527681.SGD","LU2476274308.USD","LU0039217434.USD","LU0431992006.USD","LU1044874839.SGD","BK1535","02318","03968","LU0589944569.HKD","LU0307460666.USD","LU0315179316.USD","BK1560","LU0819123356.HKD","LU2045819591.USD","00763","LU0048580855.USD","HK0000352382.USD","BK1237","LU1152091754.HKD","159982","LU0417516738.SGD","LU0593848301.USD","LU0370786039.SGD","LU0588546209.SGD","LU1960683339.HKD","LU0229945570.USD","BK1607","IE0008368742.USD","BK1514","LU1993786604.SGD","LU1242518931.SGD","LU0067412154.USD","BK1546","IE00B29SXG58.USD","LU1282651121.HKD","02218","IE00BZ08YT58.USD","LU1244550494.USD","LU0051755006.USD","03143","LU0417516571.SGD","BK1122","LU0878005551.USD","LU1211504680.USD","LU0049853897.USD","LU0640798160.USD","LU0348805143.USD","LU1813983027.USD","LU0882747503.HKD","BK1214","LU0293314216.USD","LU0164872284.USD","LU0648948544.HKD","BK1249","LU0117844026.USD","BK1530","LU1051768304.USD","HK0000252152.HKD","00916","LU0359201612.USD","LU0516422366.SGD","LU0880133367.SGD","HK0000306685.HKD","LU1688375341.USD","LU0463099449.HKD","LU1166156734.SGD","LU0890818403.SGD","BK1526","06655","LU0254981946.USD","LU1366334578.USD","LU2152927971.USD","02338","PNGAY","LU0831103253.SGD","LU0543330566.HKD","HK0000352291.HKD","LU0348766576.USD","LU1044876610.USD","LU1719994722.HKD","LU2778985437.USD","LU1769817179.HKD","LU0611395673.USD","LU1226287529.USD","LU1048596156.SGD","LU1282649067.USD","LU0672654166.SGD","LU0607220059.USD","BK1564","LU1242518857.USD","LU1794554557.SGD","LU0029875118.USD","LU1642822792.SGD","LU1720050803.USD","BK1522","LU0214875030.USD","HK0000320223.HKD","01276","LU0084288322.USD","BK1202","LU1244550221.USD","LU0197773673.USD","BK1110","BK1149","LU0210527791.USD","BK1191","HK0000500386.USD","LU0516423091.SGD","LU0231483743.USD","LU0348783662.USD","LU1282649810.SGD","BK1231","LU0181495838.USD","HK0001040168.HKD","BK1521","02691","LU0326950275.SGD","LU0348816934.USD","BK1183","00568","BK1154","LU1770034418.SGD","LU2242644610.SGD","03759","LU1655091459.SGD","02208","IE00BMCWC346.EUR","LU0823040885.USD","LU2348774022.SGD","SG9999014674.SGD","LU0819121731.USD","SG9999006597.SGD","IE00B5MMRT66.SGD","LU1046422090.SGD","LU0117841782.USD","LU0797268264.HKD","00300","LU0856984785.SGD","01057","LU0384037296.USD","LU0702159699.USD","LU1115378108.SGD","LU2153592121.USD","LU0173614495.USD","LU1224709979.USD","00042","03200","LU2226246903.HKD","LU0502904849.HKD","BK1135","BK1610","LU1105468828.SGD","01812","BK1594","LU2039709279.SGD","LU0572944931.SGD","LU0868486357.SGD","SG9999004220.SGD","LU1515016050.SGD","BK1576","LU0979878070.USD","LU0784639295.USD","LU0516422952.EUR","BK1562","IE0003895053.USD","02359","LU0588545730.USD","LU0211977185.USD","LU0011963245.USD","BK1105","LU1481107354.HKD","LU0651947912.USD","03145","LU0197773160.USD","IE0008369823.USD","LU0630378429.USD","LU1769817096.USD","IE0034224299.USD","LU0164880469.USD","HK0000320264.USD","IE00BZ08YS42.EUR","LU1048588211.SGD","LU0737861699.HKD","LU0210526637.USD","03678","LU2293587155.HKD","SG9999001903.USD","LU1251922891.USD","HK0000252160.HKD","LU0449515922.USD","LU0762541174.USD","03986","LU1328277881.USD","LU0455707207.USD","LU0594300179.USD","LU0469268626.HKD","LU0531971595.HKD","01033","LU2424517915.HKD","LU0871576103.HKD","LU0862451753.SGD","BK1171","BK1184","LU0140636845.USD","LU1008478684.HKD","601318","LU0149534421.HKD","LU2476274720.SGD","LU0348735423.USD","LU0516423174.USD","LU0348827113.USD","LU0918141887.USD","BK1529","EWH","LU0828237940.HKD","LU0228659784.USD","HK0001040143.USD","BK1125","LU1152091168.USD","02465","LU0708995583.HKD","LU1880383440.USD","LU1831875114.USD","BK1205","BK1541","LU0244354667.USD","LU0540923850.HKD","LU1303224171.USD","LU0287142896.SGD","LU1282648689.USD","IE00B3M56506.USD","IE00BZ08YR35.GBP","LU0328353924.USD","BK1141","LU0456827905.SGD","LU0516422440.USD","BK1533","LU2153591404.USD","BK1223","00598","IE0032431581.USD","01688","02768","LU0898667661.SGD","LU0594300419.USD","LU0501845795.SGD","LU0561508036.HKD","LU1981816686.USD","LU0918141705.HKD","LU0128522157.USD","IE00B543WZ88.USD","BK1583","SG9999002463.SGD","LU0359202008.SGD","LU1044875133.USD","82318","LU0543330483.HKD","HK0000286598.CNH","LU2348773727.SGD","BK1507","LU0531970944.HKD","LU0163747925.USD","IE00BVYPNP33.GBP","LU0149721374.USD","BK1116","IE00BYV24P56.USD","LU0823426480.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658010276","title":"Hengrui Pharma Gets Nod to Add Fifth Indication for Ivarmacitinib Sulfate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658010276","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658010276?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:08","pubTimestamp":1786331317,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration to add a fifth indication for its ivarmacitinib sulfate tablets or SHR0302 tablets, according to a weekend disclosure on the Hong Kong bourse.The pharmaceutical company's shares rose 1% during Monday's morning trade.The regulator approved the drug as a treatment for adult patients with active nonradiographic axial spondyloarthritis, who have had an inadequate response or intolerance to nonsteroidal anti-inflammatory drugs and who have objective signs of inflammation.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0012","BK0196","LU2097828714.EUR","BK1191","LU2488822045.USD","LU1064130708.USD","LU1969619763.USD","01276","BK0060","LU2097828805.USD","LU2328871848.SGD","LU0359201885.HKD","LU2543165471.USD","LU1064131003.USD","LU1997245177.USD","LU2097828474.EUR","LU2097828557.USD","LU1328615791.USD","LU1997244956.HKD","LU0405327148.USD","BK0239","600276","LU1255011170.USD","LU2495084118.USD","LU1820825898.SGD","LU1655091616.SGD","LU0359202008.SGD","LU2580892862.HKD","LU1023057109.AUD","LU2097828631.EUR","LU1781817850.SGD","BK0183","BK0188","LU0359201612.USD","LU1146622755.USD","LU2289578879.USD","LU2580892789.USD","LU1580142542.USD","LU0405327494.USD","LU2148510915.USD","LU1997245094.SGD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127214106","title":"Hong Kong Stocks in Focus: METIS TECHBIO-P (07666) Surges Over 16% in Morning Trade as In-House AiTEM Platform Integrates with Jiangsu Hengrui Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=1127214106","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127214106?lang=en_us&edition=fundamental","pubTime":"2026-08-10 09:38","pubTimestamp":1786325900,"startTime":"0","endTime":"0","summary":"METIS TECHBIO-P (07666) shares climbed more than 16% during early trading on the Hong Kong Stock Exchange, last changing hands at HK$12.87, representing a 15.74% gain with turnover reaching...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","KCAI","NEWZ","NBDS","QQQM","LU1969619763.USD","BK4593","LU2495084118.USD","03086","LU1997245094.SGD","PBOT","LU0359202008.SGD","MFIG","BK0188","QTOC","DQJN","LU1655091616.SGD","03034","QQA","LU2097828805.USD","QSWN","QQQ","QMAR","PSQ","GPIQ","09086","LU2580892862.HKD","CWC","BK0060","BK0183","AIFD","NJAN","AQGX","NOCT","LU2148510915.USD","09834","TQQQ","LU0405327494.USD","07666","LU1146622755.USD","LU1997244956.HKD","LU2543165471.USD","BK1161","LU0359201612.USD","MVPS","GK","LU1023057109.AUD","OGIG","BK4585","AIBU","LU1580142542.USD","LU2328871848.SGD","03455","LU1064130708.USD","LU1064131003.USD","VUSE","QDEC","600276","VXUS","LU2097828474.EUR","KOMP","SQQQ","BK0196","07522","07568","161631","LU2289578879.USD","02834","CHAT","LU2488822045.USD","BK0239","QID","LU2580892789.USD","TECY","07266","QQQX","LU0359201885.HKD","LU2097828714.EUR","BK1191","ARTY","NAPR","LU1820825898.SGD","LCLG","AGIX","LU2097828557.USD","BK0012","01276","LU1997245177.USD","LU0405327148.USD","QLD","BK0028","07261","CPNQ","TQQY","BK4588","WPAI","FWD","NJUL","AIQU","LU1255011170.USD","LU1781817850.SGD","LU2097828631.EUR","TARK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198378336","title":"Hengrui Pharma Prioritizes Stable Business Performance to Sustain Long-Term Value and Reward Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1198378336","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198378336?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:41","pubTimestamp":1786113674,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (ticker: 600276) responded to investor inquiries on its interactive platform, stating that the company consistently adheres to a strategy of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","BK0188","LU2289578879.USD","LU0359201885.HKD","LU1997244956.HKD","LU0405327148.USD","LU2097828631.EUR","LU1255011170.USD","LU1997245094.SGD","LU1064130708.USD","BK0196","LU2148510915.USD","LU2328871848.SGD","01276","LU1023057109.AUD","LU2097828557.USD","LU2488822045.USD","LU2097828714.EUR","LU0359202008.SGD","BK0012","LU1146622755.USD","BK0028","BK0239","BK1191","600276","LU0405327494.USD","LU2580892862.HKD","LU2097828474.EUR","BK0060","LU1328615791.USD","LU0359201612.USD","LU1781817850.SGD","LU1969619763.USD","LU1580142542.USD","LU2580892789.USD","LU1655091616.SGD","LU2495084118.USD","LU1997245177.USD","LU2097828805.USD","BK0183","LU1820825898.SGD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107727624","title":"HENGRUI PHARMA Continues to Reward Shareholders Through Dividends and Other Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=1107727624","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107727624?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:40","pubTimestamp":1786113627,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (HENGRUI PHARMA) responded to investor inquiries on its interactive platform, stating that since its A-share listing in 2000, the company raised...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1328615791.USD","BK0188","LU1997245177.USD","VIG","LU1580142542.USD","LU2097828631.EUR","LU2289578879.USD","LU2580892789.USD","LU1997245094.SGD","LU0405327494.USD","LU2097828714.EUR","LU0359201612.USD","LU1997244956.HKD","BK0239","LU2097828557.USD","LU2495084118.USD","BK0196","LU1255011170.USD","LU1781817850.SGD","LU0359201885.HKD","BK0028","BK1191","LU1146622755.USD","LU0359202008.SGD","BK0012","LU2097828805.USD","LU1969619763.USD","LU2580892862.HKD","LU1064131003.USD","LU2328871848.SGD","LU2097828474.EUR","LU1655091616.SGD","01276","BK0183","BK0060","BK4588","LU1023057109.AUD","LU1820825898.SGD","BK4585","LU2543165471.USD","LU0405327148.USD","LU2488822045.USD","600276","LU1064130708.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170067772","title":"Jiangsu Hengrui Pharmaceuticals Focuses on Core Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1170067772","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170067772?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:21","pubTimestamp":1786105298,"startTime":"0","endTime":"0","summary":"On August 7, Jiangsu Hengrui Pharmaceuticals Co.,Ltd. responded to investor inquiries on its interactive platform, stating that secondary market stock price fluctuations are influenced by a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","LU2488822045.USD","LU0405327148.USD","LU0359202008.SGD","LU1064130708.USD","BK0028","LU2097828557.USD","01276","600276","LU1655091616.SGD","LU1969619763.USD","LU2097828714.EUR","LU2328871848.SGD","BK0239","LU1997245094.SGD","LU1580142542.USD","LU2097828805.USD","BK0183","LU1820825898.SGD","LU1023057109.AUD","LU2543165471.USD","LU1146622755.USD","LU1997245177.USD","LU2289578879.USD","LU1064131003.USD","LU1997244956.HKD","LU2097828474.EUR","LU2148510915.USD","LU0359201885.HKD","BK0188","LU0359201612.USD","LU2580892789.USD","LU2580892862.HKD","LU1255011170.USD","LU1328615791.USD","LU2097828631.EUR","LU2495084118.USD","LU1781817850.SGD","BK0060","BK0012","BK0196","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657199906","title":"Citigroup's Short Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 1.39% on Aug 3 from 2.36% - HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2657199906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657199906?lang=en_us&edition=fundamental","pubTime":"2026-08-07 17:16","pubTimestamp":1786094172,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN4432LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0405327148.USD","LU0359201612.USD","LU2543165471.USD","LU1781817850.SGD","LU0359202008.SGD","BK0183","BK0060","LU1820825898.SGD","LU2097828474.EUR","LU2580892789.USD","LU1997245094.SGD","LU2097828714.EUR","LU1328615791.USD","LU2289578879.USD","BK0188","LU0405327494.USD","LU1997244956.HKD","LU1064130708.USD","LU2495084118.USD","LU1064131003.USD","LU1969619763.USD","LU2097828557.USD","01276","LU2097828805.USD","LU1655091616.SGD","BK1191","LU2148510915.USD","BK0028","LU1023057109.AUD","BK0012","LU1146622755.USD","LU1580142542.USD","LU2097828631.EUR","BK0196","LU1255011170.USD","600276","LU2580892862.HKD","LU2328871848.SGD","LU2488822045.USD","LU1997245177.USD","BK0239","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148550904","title":"August 7th A-H Share Premium Data Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=1148550904","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148550904?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:24","pubTimestamp":1786091046,"startTime":"0","endTime":"0","summary":"At the close of trading on August 7th, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033) held the top three positions in the A-H share premium ranking, with premiums of 1006.56%,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1514","LU0672654166.SGD","00553","LU0315179316.USD","BK1554","LU0979878070.USD","LU0196878994.USD","LU2153591404.USD","LU1282649810.SGD","LU0708995583.HKD","LU1655091459.SGD","HK0000352291.HKD","IE0008368742.USD","LU2125910500.SGD","HK0000286598.CNH","LU0067412154.USD","LU0469268626.HKD","HK0000500386.USD","03143","LU0588545490.SGD","BK1205","HK0000151867.HKD","IE00B543WZ88.USD","LU1642822792.SGD","SG9999006597.SGD","00568","IE0031814852.USD","LU0516423174.USD","LU1807302812.USD","BK1170","BK1135","LU1981816686.USD","LU2424517915.HKD","LU0181495838.USD","LU0348784397.USD","LU0029875118.USD","LU0370786039.SGD","LU0611395673.USD","PAImain","HK0001040168.HKD","03308","BK1154","LU1303224171.USD","BK1607","LU0516422952.EUR","LU0862451837.USD","LU0828237940.HKD","LU0228659784.USD","LU2348773727.SGD","SG9999011746.SGD","BK1214","LU1481107354.HKD","HK0000320264.USD","LU1960683339.HKD","06745","SG9999002562.SGD","LU0588546209.SGD","LU0431992006.USD","SG9999002463.SGD","IE00B031HY20.USD","BK1223","HPAD.SI","03750","LU0327786744.USD","LU0898667661.SGD","LU0051755006.USD","IE0032431581.USD","LU2476274720.SGD","LU1226287529.USD","BK1529","LU0048580855.USD","LU0348827113.USD","LU0878004406.USD","LU1244550494.USD","LU0441854154.USD","BK1530","BK1184","BK1503","02318","LU2153592121.USD","LU0572944931.SGD","BK1562","BK1163","LU0359201885.HKD","LU0651946864.USD","LU0762541174.USD","LU0197773160.USD","BK1526","LU0320764599.SGD","LU0348767384.USD","00763","BK1583","BK1522","LU0890818403.SGD","LU0043850808.USD","EWH","LU0561508036.HKD","BK1507","LU1188198961.HKD","LU0307460666.USD","01688","LU0531970944.HKD","LU1051769294.HKD","BK1237","LU0516422366.SGD","LU0650527681.SGD","LU0594300419.USD","LU0651947912.USD","03145","LU0543330566.HKD","LU0821914370.USD","03678","LU0918141887.USD","LU0516423091.SGD","LU1048596156.SGD","LU1044874839.SGD","LU0831093199.SGD","LU2226246903.HKD","HK0001040143.USD","LU0328353924.USD","LU1105468828.SGD","LU2152927971.USD","06655","BK1125","LU1251922891.USD","LU0417516738.SGD","IE00BZ08YR35.GBP","LU1211504680.USD","06881","LU0797268264.HKD","SG9999004220.SGD","LU0862451753.SGD","02475","BK1576","LU0229945570.USD","LU0173614495.USD","02465","HK0000306701.USD","LU1880383366.USD","LU0072462343.USD","LU0072913022.USD","LU0106252389.USD","82318","BK1110","LU1813983027.USD","LU0084288322.USD","01349","LU0117844026.USD","BK1533","LU0348766576.USD","01812","03986","HK0000352382.USD","01033","BK1240","LU0164865239.USD","LU1282649141.HKD","LU0254981946.USD","LU0630378429.USD","LU0791591158.USD","LU2242644610.SGD","LU1023057109.AUD","02208","IE00B031J352.USD","LU1152091754.HKD","BK1551","BK1231","LU0417516571.SGD","IE00BZ08YT58.USD","LU0819121731.USD","LU0384037296.USD","IE00BVYPNQ40.USD","00956","LU1115378108.SGD","LU0348805143.USD","LU0702159343.USD","LU0878005551.USD","LU1282649067.USD","LU0165289439.USD","HK0000252160.HKD","LU0456827905.SGD","02338","LU2293587155.HKD","LU0784639295.USD","LU0244354667.USD","LU0315178854.USD","LU0640798160.USD","LU0823040885.USD","IE0003895053.USD","00598","LU1675838814.USD","SG9999000459.SGD","BK1171","LU0117841782.USD","03968","LU2294711473.HKD","LU0049853897.USD","BK1151","LU0149721374.USD","LU0831103253.SGD","LU1224444064.USD","LU1366334578.USD","LU2348774022.SGD","01057","BK1249","LU1769817179.HKD","LU0588545730.USD","BK1546","00042","LU0463099449.HKD","LU1046422090.SGD","LU0163747925.USD","LU1831875114.USD","BK1541","LU2476274308.USD","LU0149534421.HKD","LU0293314216.USD","LU0320764755.SGD","LU1808992512.USD","LU0607220059.USD","LU0823426480.USD","BK1144","HK0000252152.HKD","LU1235295612.USD","LU0762542818.HKD","LU0106959298.USD","LU1242518857.USD","159982","LU0359202008.SGD","02768","LU0348783662.USD","IE00BYV24P56.USD","LU0211977185.USD","LU0449515922.USD","LU1328277881.USD","06127","02218","BK1166","LU1044875133.USD","LU1769817096.USD","LU0348816934.USD","LU1282648689.USD","BK1560","IE00B3M56506.USD","LU0531971595.HKD","LU0235996351.USD","01276","HK0000320223.HKD","LU1048588211.SGD","SG9999001903.USD","IE00B29SXG58.USD","00916","LU1282651121.HKD","LU0856984785.SGD","LU0501845795.SGD","LU0348788117.USD","LU0918141705.HKD","LU1820825898.SGD","BK1521","LU0052750758.USD","BK1564","LU1961090484.USD","SG9999002828.SGD","LU0197773673.USD","IE00B0169L03.USD","LU0210526637.USD","01108","LU0828237510.HKD","BK1202","LU0882747503.HKD","BK1594","LU0231483743.USD","BK1116","BK1183","LU1515016050.SGD","IE00BF5LJ272.USD","LU1166156734.SGD","LU2039709279.SGD","LU0164872284.USD","LU0594300179.USD","LU0605514214.HKD","LU1152091168.USD","LU0314109678.HKD","LU0348814723.USD","LU0648948544.HKD","LU1993786604.SGD","06613","IE0008369823.USD","LU0675040207.SGD","BK1122","BK1558","LU0455707207.USD","BK1191","LU0054450605.USD","02359","LU0880133367.SGD","LU1688375341.USD","LU0488056044.USD","LU0516422440.USD","LU1224709979.USD","LU0039217434.USD","LU0868486357.SGD","LU0164880469.USD","LU0456846285.SGD","LU1880383440.USD","LU0228367735.SGD","IE00BZ08YS42.EUR","LU1770034418.SGD","IE00B5MMRT66.SGD","LU0819123356.HKD","LU0823426308.USD","LU1044876610.USD","BK1149","LU2543165471.USD","LU0737861699.HKD","601318","BK1610","BK1506","LU0011963245.USD","LU0589944569.HKD","LU0417516902.SGD","LU2045819591.USD","LU0326950275.SGD","LU0634319403.HKD","LU0140636845.USD","LU0348735423.USD","HK0000306685.HKD","BK1147","LU0287142896.SGD","LU0540923850.HKD","LU2399975544.HKD","BK1141","SG9999014674.SGD","LU1146622755.USD","LU1244550221.USD","BK1535","LU0214875030.USD","LU1282651048.USD","LU0865486749.SGD","LU0702159699.USD","IE00BGHQDM52.EUR","BK1105","IE00BMCWC346.EUR","LU0348783233.USD","BK1505","LU1242518931.SGD","00991","LU0502904849.HKD","00300","LU1794554557.SGD","LU1719994722.HKD","LU0543330483.HKD","BK1513","03200","LU0049112450.USD","LU0210527791.USD","LU0593848301.USD","BK1502","LU0630378692.HKD","LU1720050803.USD","LU0359201612.USD","PNGAY","LU1051768304.USD","LU2778985437.USD","LU0791590937.USD","LU0348825331.USD","LU0449509016.USD","LU1366334651.USD","LU0762540952.USD","BK1550","IE00BVYPNP33.GBP","399300","LU0871576103.HKD","LU0128522157.USD","LU1244550577.SGD","LU1008478684.HKD","LU0588545904.SGD","IE0034224299.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177922465","title":"HENGRUI PHARMA Shares Surge Over 4% in Late Trading as China's First Anti-HER2 Product for Colorectal Cancer Gains Market Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1177922465","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177922465?lang=en_us&edition=fundamental","pubTime":"2026-08-07 15:24","pubTimestamp":1786087459,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) shares climbed more than 4% in late trading, currently up 3.9% to HK$58.6, with a trading volume of HK$220 million. On August 6, the company announced that the third indication...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU2495084118.USD","LU1997244956.HKD","VXUS","600276","LU0405327494.USD","BK4585","BK0012","BK1191","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","LU1023057109.AUD","LU2580892862.HKD","BK0028","LU0359201612.USD","BK0188","BK0239","LU1328615791.USD","01276","LU2097828557.USD","LU2289578879.USD","BK4588","BK0060","LU0359201885.HKD","LU1146622755.USD","LU1655091616.SGD","LU1820825898.SGD","LU2097828474.EUR","LU2097828805.USD","LU2488822045.USD","BK0196","LU2097828714.EUR","LU2580892789.USD","LU1580142542.USD","LU1997245094.SGD","LU1781817850.SGD","LU2148510915.USD","LU1255011170.USD","LU1064130708.USD","KCAI","LU0359202008.SGD","BK0183","LU2543165471.USD","IPOS","LU0405327148.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185344761","title":"Movement Alert｜HENGRUI PHARMA Rises 3.1% in Regular Trading, Two Innovative Drugs Approved for New Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1185344761","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185344761?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:21","pubTimestamp":1786080078,"startTime":"0","endTime":"0","summary":"On August 7, HENGRUI PHARMA rose 3.1% in regular trading, trading at HKD 57.9/share, with turnover of HKD 131 million.The rally was primarily driven by the simultaneous approval of two innovative...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634143","title":"Hengrui Pharma Unit Gets Marketing Nod for Colorectal Cancer Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634143","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634143?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:54","pubTimestamp":1786020887,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Suzhou Suncadia Biopharmaceuticals' third indication for trastuzumab rezetecan for injection was approved for marketing by China's National Medical Products Administration.The drug is now the first anti-HER2 product approved for the treatment of colorectal cancer in China.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","LU0359201612.USD","01276","LU0359202008.SGD","LU0359201885.HKD","BK1191","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165330909","title":"Hengrui Pharma Secures China’s First Anti-HER2 Approval for Colorectal Cancer with Trastuzumab Rezetecan","url":"https://stock-news.laohu8.com/highlight/detail?id=1165330909","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165330909?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:44","pubTimestamp":1786020250,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276) has received National Medical Products Administration (NMPA) clearance for a third indication of its in-house developed antibody-drug...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657631627","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approved Additional (Fifth) Indication for Ivarmacitinib Sulfate Tablets (Shr0302 Tablets)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657631627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657631627?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:40","pubTimestamp":1786020015,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0359201612.USD","LU1328615791.USD","LU2580892862.HKD","LU1064131003.USD","01276","LU2097828805.USD","LU1023057109.AUD","600276","LU2495084118.USD","BK1191","LU2289578879.USD","LU1064130708.USD","LU1655091616.SGD","LU2097828557.USD","LU1146622755.USD","LU1997245177.USD","LU2097828474.EUR","BK0183","BK0188","LU0359201885.HKD","LU2580892789.USD","BK0196","LU1997245094.SGD","BK0060","LU1820825898.SGD","LU2543165471.USD","BK0239","LU1781817850.SGD","LU2488822045.USD","LU2097828714.EUR","LU1580142542.USD","LU0405327148.USD","LU0359202008.SGD","LU2328871848.SGD","LU1969619763.USD","LU1997244956.HKD","BK0012","BK0028","LU1255011170.USD","LU0405327494.USD","LU2148510915.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657327631","title":"Jiangsu Hengrui Pharmaceuticals - Nmpa Approves Third Indication for Trastuzumab Rezetecan for Injection for Marketing in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657327631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657327631?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:34","pubTimestamp":1786019685,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44319M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0359202008.SGD","LU1023057109.AUD","BK0060","BK0239","LU2488822045.USD","LU2328871848.SGD","LU2495084118.USD","LU2148510915.USD","BK0196","LU1969619763.USD","600276","LU2097828557.USD","LU2580892862.HKD","LU0405327494.USD","LU1064130708.USD","LU1781817850.SGD","LU2289578879.USD","LU1820825898.SGD","LU1328615791.USD","LU1064131003.USD","BK0183","LU1655091616.SGD","LU2097828474.EUR","LU2580892789.USD","LU1255011170.USD","LU1997245177.USD","LU2097828714.EUR","LU0359201612.USD","LU2097828631.EUR","BK0012","01276","LU1146622755.USD","BK0188","LU0405327148.USD","BK1191","BK0028","LU0359201885.HKD","LU1580142542.USD","LU1997244956.HKD","LU1997245094.SGD","LU2543165471.USD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142719906","title":"JAK1 Inhibitor Aisuda Secures Fifth Indication Approval for Active Non-Radiographic Axial Spondyloarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=1142719906","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142719906?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018284,"startTime":"0","endTime":"0","summary":"A pivotal Phase III study has met its primary endpoint, with the Aisuda (ivarmacitinib sulfate) group achieving a 39.7% ASAS40 response rate at 12 weeks, compared to 24.8% in the placebo group...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","LU0359201885.HKD","AS","01276","BK4202","BK1191","LU0359201612.USD","LU1023057109.AUD","LU0359202008.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167903648","title":"Jiangsu Hengrui Pharmaceuticals Secures Approval for Third Indication of Its Anti-HER2 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1167903648","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167903648?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:40","pubTimestamp":1786016414,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH) has announced that its subsidiary, Suzhou Sundia Biopharmaceuticals Co., Ltd., received approval from the National Medical Products Administration...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU1328615791.USD","BK0028","LU2488822045.USD","LU1997245094.SGD","LU2097828631.EUR","BK0188","LU0405327494.USD","LU2148510915.USD","LU1064131003.USD","LU2580892862.HKD","LU2495084118.USD","BK0060","LU0359201612.USD","LU2097828805.USD","LU0359202008.SGD","LU0359201885.HKD","LU0405327148.USD","600276","LU1255011170.USD","LU1655091616.SGD","BK1191","LU2328871848.SGD","LU1023057109.AUD","LU1580142542.USD","LU1064130708.USD","LU2580892789.USD","LU2097828714.EUR","LU1781817850.SGD","LU2097828474.EUR","LU1997245177.USD","IPOS","BK0239","LU1820825898.SGD","LU1997244956.HKD","LU1969619763.USD","LU2543165471.USD","01276","LU2289578879.USD","BK0196","BK0183","BK0012","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657031682","title":"Citigroup’s Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Increases to 5.06% on July 31 from 4.46% - HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2657031682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657031682?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012206,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4430J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1064130708.USD","BK0196","LU2580892789.USD","LU2097828714.EUR","BK1191","BK0028","LU1655091616.SGD","LU2289578879.USD","LU0405327494.USD","LU1781817850.SGD","LU2097828557.USD","LU2543165471.USD","LU1997245177.USD","LU0405327148.USD","BK0188","LU1146622755.USD","LU1328615791.USD","LU1580142542.USD","LU2097828474.EUR","LU2097828805.USD","LU2148510915.USD","BK0239","LU1997245094.SGD","LU1064131003.USD","LU2328871848.SGD","LU2580892862.HKD","BK0012","BK0060","LU0359201885.HKD","LU0359202008.SGD","LU1997244956.HKD","LU2488822045.USD","LU2495084118.USD","600276","LU1820825898.SGD","LU1023057109.AUD","LU0359201612.USD","LU1255011170.USD","LU1969619763.USD","LU2097828631.EUR","BK0183","01276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}